Besides BCR-ABL1 fusion gene, the ETV6/RUNX1 (E/R) mutation is frequently found in childhood B-ALL and literature reported the importance of using dual PI3K/mTOR drugs for a marked inhibition of cells harbouring E/R mutation and a decreased cell resistance to glucocorticoids [136]. This evidence concerns the gene ABL1 and acute lymphoblastic leukemia.